Modern Pediatrics. Ukraine. (2024). 4(140): 97-112. doi: 10.15574/SP.2024.140.97
Dorosh O. I.^1,2, Voloshchuk V. B.¹, Dushar M. I.³, Melko I. P.^2,4, Zhelоv V. I.¹, Romanishyn B. S.¹, Kuzyk A. S.^1,2, Petronchak O. A.⁵, Hulei R. V.⁵, Dudash A. P.⁵, Skaletska N. M.^2
1СNE of Lviv Regional Council «Western Ukrainian Specialized Pediatric Medical Centre», Ukraine
²Danylo Halytsky Lviv National Medical University, Ukraine
³Laboratory center “Leogenе”, Lviv, Ukraine
⁴Municipal non-profit enterprise "Lviv territorial medical union "multidisciplinary clinical hospital of emergency and intensive care" St. Luke's Hospital"
⁵PLC «Western Histology Laboratory», Lviv, Ukraine

For citation: Dorosh OI, Voloshchuk VB, Dushar MI, Melko IP, Zhelоv VI, Romanishyn BS et al. (2024). Ulcerative colitis, hereditary spherocytosis and haemochromatosis in a child: an integrated approach to clinical case management. Modern Pediatrics. Ukraine. 4(140): 97–112. doi: 10.15574/SP.2024.140.97.
Article received: Mar 03, 2024. Accepted for publication: May 14, 2024.

Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), is a chronic systemic idiopathic pathology of the intestinal tract with extraintestinal manifestations (EIM) in some patients. One of the most common complications in these patients is anemia, which can be the result of iron, vitamin B₁₂ or B₉ deficiency; intestinal absorption disorders or autoimmune hemolysis.
Aim – to describe a rare clinical case of a 10-year and 10-month-old boy diagnosed with UC and EIM, hereditary spherocytosis (HS) caused by a heterozygous ANK1 gene-mutation and hereditary hemochromatosis associated with a pathogenic HFE gene- mutation. This case underscores the importance of genetic testing, pathological examinations, and accurate interpretation of peripheral blood smear morphology for disease diagnosis.
Clinical case. We present a unique combination of UC with EIM, НS caused by a pathogenic heterozygous mutation in the ANK1 gene (exon c.2394_2397del (p.Ser799Ilefs*5)), and hereditary hemochromatosis with a heterozygous pathogenic mutation in the HFE gene (exon c.187C>G (p.His63Asp) in a boy aged 10 years 10 months. The child was abdominal and right hip pain, abdominal enlargement. Diagnosis of HS and hemochromatosis was confirmed through whole-genome sequencing and pathological examination of the spleen. UC with EIM (by Pediatric Ulcerative Colitis Activity Index – 15 points) diagnosed based on clinical presentation, colonoscopy, laboratory tests (elevated IgG antibodies to proteinase 3 and inflammatory changes in the blood). This case emphasizes the crucial role of molecular genetic testing and careful analysis of peripheral blood smears by cytologists in the accurate diagnosis of complex diseases.
The research was carried out in accordance with the principles of the Helsinki Declaration. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the authors.
Keywords: nonspecific ulcerative colitis, hereditary spherocytosis, ANK1-mutation, hereditary haemochromatosis, HFE-mutation, full-exome sequencing, pathohistological examination.
REFERENCES

1. Adeniyi OF Sr, Odeghe E, Olatona FA, Lawal M, Onywekwelu VI et al. (2020). Inflammatory bowel disease in children: experience and constraints in a resource-limited setting. Cureus. 12(4): e7848. https://doi.org/10.7759/cureus.7848

2. Adhiah AH, Jasim HA, Fadhil AM. (2008). HLA antigens and inflammatory bowel disease in a sample of Iraqi patients. East Mediterr Health J. 14(5): 1155-1163.

3. Agrawal M, Spencer EA, Colombel JF, Ungaro RC. (2021). Approach to the management of recently diagnosed inflammatory bowel disease patients: a user's guide for adult and pediatric gastroenterologists. Gastroenterology. 161(1): 47-65. https://doi.org/10.1053/j.gastro.2021.04.063; PMid:33940007 PMCid:PMC8640961

4. Alatise OI, Otegbayo JA, Nwosu MN, Lawal OO, Ola SO, Anyanwu SN et al. (2012). Characteristics of inflammatory bowel disease in three tertiary health centers in southern Nigeria. West Afr J Med. 31(1): 28-33.

5. Annese V. (2020). Genetics and epigenetics of IBD. Pharmacol Res. 159: 104892. https://doi.org/10.1016/j.phrs.2020.104892; PMid:32464322

6. Atuğ Ö, Kani HT, Banzragch M, İmeryüz N, Akın H. (2016). Incidence rate of anemia in inflammatory bowel diseases. Turk J Gastroenterol. 27(2): 143-148. https://doi.org/10.5152/tjg.2016.16011; PMid:27015619

7. Aziz DA, Moin M, Majeed A, Sadiq K, Biloo AG. (2017). Paediatric inflammatory bowel disease: clinical presentation and disease location. Pak J Med Sci. 33(4): 793-797. https://doi.org/10.12669/pjms.334.12926; PMid:29067041 PMCid:PMC5648940

8. Bianchi P, Fermo E, Vercellati C, Marcello AP, Porretti L, Cortelezzi A et al. (2012). Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics. Haematologica. 97(4): 516-523. https://doi.org/10.3324/haematol.2011.052845; PMid:22058213 PMCid:PMC3347664

9. Bianco C, Coluccio E, Prati D, Valenti L. (2021). Diagnosis and management of autoimmune hemolytic anemia in patients with liver and bowel disorders. J Clin Med. 10(3): 423. https://doi.org/10.3390/jcm10030423; PMid:33499290 PMCid:PMC7865399

10. Bock I, Perrin J, Braun F, Garçon L, Lesesve JF. (2012). A case of hereditary pyropoikilocytosis with mild expression and delayed onset. Ann Biol Clin (Paris). 70(4): 483-488. https://doi.org/10.1684/abc.2012.0710; PMid:22796621

11. Branco CC, Gomes CT, De Fez L, Bulhões S, Brilhante MJ, Pereirinha T et al. (2015). Carriers of the complex allele HFE c.[187C>G;340+4T>C] have increased risk of iron overload in São Miguel Island population (Azores, Portugal). PLoS One. 10(10): e0140228. https://doi.org/10.1371/journal.pone.0140228; PMid:26501199 PMCid:PMC4621060

12. Brissot P, Pietrangelo A, Adams PC, de Graaff B, McLaren CE, Loréal O. (2018). Haemochromatosis. Nat Rev Dis Primers. 4: 18016. https://doi.org/10.1038/nrdp.2018.16; PMid:29620054 PMCid:PMC7775623

13. Casale M, Perrotta S. (2011). Splenectomy for hereditary spherocytosis: complete, partial or not at all? Expert Review of Hematology. 4(6): 627-635. https://doi.org/10.1586/ehm.11.51; PMid:22077527

14. Cassinotto C, Lapuyade B, Mouries A et al. (2014). Noninvasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and Fibroscan. J Hepatol. 61: 550-557. https://doi.org/10.1016/j.jhep.2014.04.044; PMid:24815876

15. Chairunnisa N, Pratiwi J, Rose Diana Kusumawati N. (2023). Comparison of PUCAI score in mesalazine-treated children with ulcerative colitis. Arch Pediatr Gastr Hepatol Nutr [Internet]. 2(2): 18-24. URL: https://apghn.com/index.php/journal/article/view/39. https://doi.org/10.58427/apghn.2.2.2023.18-24

16. Chams S, Badran R, Sayegh SE, Chams N, Shams A, Hajj Hussein I. (2019). Inflammatory bowel disease: Looking beyond the tract. Int J Immunopathol Pharmacol. 33: 2058738419866567. https://doi.org/10.1177/2058738419866567; PMid:31382828 PMCid:PMC6685113

17. Childers RE, Eluri S, Vazquez C, Weise RM, Bayless TM, Hutfless S. (2014). Family history of inflammatory bowel disease among patients with ulcerative colitis: a systematic review and meta-analysis. J Crohns Colitis. 8(11): 1480-1497. https://doi.org/10.1016/j.crohns.2014.05.008; PMid:24974207

18. Cho M, Tucker S, Choi L. (2021). Hereditary spherocytosis as an atypical presentation of anemia in ulcerative colitis. JPGN Rep. 2(3): e086. https://doi.org/10.1097/PG9.0000000000000086; PMid:37205956 PMCid:PMC10191523

19. Christensen RD, Henry E. (2010). Hereditary spherocytosis in neonates with hyperbilirubinemia. Pediatrics. 125(1): 120-125. https://doi.org/10.1542/peds.2009-0864; PMid:19948573

20. Colman RJ, Dhaliwal J, Rosen MJ. (2021). Predicting therapeutic response in pediatric ulcerative colitis – a journey towards precision medicine. Front Pediatr. 9: 634739. https://doi.org/10.3389/fped.2021.634739; PMid:33681110 PMCid:PMC7925616

21. Corica D, Romano C. (2016). Renal involvement in inflammatory bowel diseases. J Crohns Colitis. 10(2): 226-235. https://doi.org/10.1093/ecco-jcc/jjv138; PMid:26223844

22. Cortez RV, Moreira LN, Padilha M, Bibas MD, Toma RK, Porta G, Taddei CR. (2021). Gut microbiome of children and adolescents with primary sclerosing cholangitis in association with ulcerative colitis. Front Immunol. 11: 598152. https://doi.org/10.3389/fimmu.2020.598152; PMid:33613519 PMCid:PMC7893080

23. Danise P, Amendola G, Nobili B, Perrotta S, Miraglia Del Giudice E et al. (2001). Flow-cytometric analysis of erythrocytes and reticulocytes in congenital dyserythropoietic anaemia type II (CDA II): value in differential diagnosis with hereditary spherocytosis. Clin Lab Haematol. 23(1): 7-13. https://doi.org/10.1046/j.1365-2257.2001.00354.x; PMid:11422224

24. Dybowska A, Krogulska A. (2023). Autoimmune haemolytic anaemia as a rare and potentially serious complication of Crohn's disease in a 11-year-old child – case report and minireview. Children (Basel). 10(10): 1698. https://doi.org/10.3390/children10101698; PMid:37892361 PMCid:PMC10605867

25. Emilse LAM, Cecilia H, María TM, Eugenia MM, Alicia IB, Lazarte SS. (2018). Cryohemolysis, erythrocyte osmotic fragility, and supplementary hematimetric indices in the diagnosis of hereditary spherocytosis. Blood Res. 53(1): 10-17. https://doi.org/10.5045/br.2018.53.1.10; PMid:29662857 PMCid:PMC5898988

26. Filmann N, Rey J, Schneeweiss S, Ardizzone S, Bager P, Bergamaschi G et al. (2014). Prevalence of anemia in inflammatory bowel diseases in european countries: a systematic review and individual patient data meta-analysis. Inflamm Bowel Dis. 20(5): 936-945. https://doi.org/10.1097/01.MIB.0000442728.74340.fd; PMid:24572205

27. Gao H, Zheng S, Yuan X, Xie J, Xu L. (2023). Causal association between inflammatory bowel disease and 32 site-specific extracolonic cancers: a Mendelian randomization study. BMC Med. 21(1): 389. https://doi.org/10.1186/s12916-023-03096-y; PMid:37817217 PMCid:PMC10566178

28. Gertz MA. (2022). Updates on the diagnosis and management of cold autoimmune hemolytic anemia. Hematol Oncol Clin North Am. 36(2): 341-352. https://doi.org/10.1016/j.hoc.2021.11.001; PMid:35282954 PMCid:PMC9088174

29. Gheorghe G, Bungău S, Ceobanu G, Ilie M, Bacalbaşa N, Bratu OG et al. (2021). The non-invasive assessment of hepatic fibrosis. J Formos Med Assoc. 120(2): 794-803. Epub 2020 Aug 26. doi: 10.1016/j.jfma.2020.08.019. PMID: 32861550. https://doi.org/10.1016/j.jfma.2020.08.019; PMid:32861550

30. Güngör Ö, Sarsık B, Tatar E, Akarca US, Tekeşin O, Sezak M, Başcı A. (2013). Inflammatory bowel disease presenting with nephrotic syndrome and cholestasis. Turk J Gastroenterol. 24(6): 568-569. https://doi.org/10.4318/tjg.2013.0835; PMid:24623302

31. Gupta S, Piefer CL, Fueger JT, Johnson ST, Punzalan RC. (2010). Trimethoprim-induced immune hemolytic anemia in a pediatric oncology patient presenting as an acute hemolytic transfusion reaction. Pediatr Blood Cancer. 55(6): 1201-1203. https://doi.org/10.1002/pbc.22648; PMid:20589632

32. He BJ, Liao L, Deng ZF, Tao YF, Xu YC, Lin FQ. (2018). Molecular genetic mechanisms of hereditary spherocytosis: current perspectives. Acta Haematol. 139(1): 60-66. https://doi.org/10.1159/000486229; PMid:29402830

33. Huang TL, Sang BH, Lei QL, Song CY, Lin YB, Lv Y et al. (2019). A de novo ANK1 mutation associated to hereditary spherocytosis: a case report. BMC Pediatr. 19(1): 62. https://doi.org/10.1186/s12887-019-1436-4; PMid:30777044 PMCid:PMC6379977

34. Hyams JS, Brimacombe M, Haberman Y, Walters T, Gibson G, Mo A et al. (2022). Clinical and host biological factors predict colectomy risk in children newly diagnosed with ulcerative colitis. Inflamm Bowel Dis. 28(2): 151-160. https://doi.org/10.1093/ibd/izab061; PMid:33904583 PMCid:PMC8804885

35. Jang HJ, Suh HR, Choi S, Hong SJ, Cho SM, Choi KH et al. (2021). Severe disease activity based on the Paris classification is associated with the development of extraintestinal manifestations in Korean children and adolescents with ulcerative colitis. J Korean Med Sci. 36(44): e278. https://doi.org/10.3346/jkms.2021.36.e278; PMid:34783212 PMCid:PMC8593413

36. Jitraruch S, Fitzpatrick E, Deheragoda M, Deganello A, Mieli-Vergani G, Height S et al. (2017). Autoimmune liver disease in children with sickle cell disease. J Pediatr. 189: 79-85.e2. https://doi.org/10.1016/j.jpeds.2017.06.035; PMid:28735981

37. Johns HR, Shetty N, Cash J, Patel T, Pourciau C. (2022). Bowel-Associated-Dermatosis-Arthritis Syndrome (BADAS) as early presentation of ulcerative colitis in an adolescent girl. Pediatr Dermatol. 39(4): 643-645. https://doi.org/10.1111/pde.14954; PMid:35191547

38. Kane SF, Roberts C, Paulus R. (2021). Hereditary hemochromatosis: rapid evidence review. Am Fam Physician. 104(3): 263-270. PMID: 34523883.

39. Katsarou MS, Papasavva M, Latsi R, Drakoulis N. (2019). Hemochromatosis: hereditary hemochromatosis and HFE gene. Vitam Horm. 110: 201-222. https://doi.org/10.1016/bs.vh.2019.01.010; PMid:30798813

40. Kobayashi M, Takeuchi I, Kubota M, Ishiguro A, Arai K. (2022). Severe hip arthritis as an initial presenting symptom of pediatric ulcerative colitis. Pediatr Int. 64(1): e15067. https://doi.org/10.1111/ped.15067; PMid:35484916

41. Kwon Y, Kim ES, Choe YH, Kim MJ. (2022). Increased demand for therapeutic drugs in pediatric ulcerative colitis patients with extraintestinal manifestations. Front Pediatr. 10: 853019. https://doi.org/10.3389/fped.2022.853019; PMid:35676896 PMCid:PMC9170076

42. Laass MW, Ziesmann J, de Laffolie J, Röber N, Conrad K. (2022). Anti-proteinase 3 antibodies as a biomarker for ulcerative colitis and primary sclerosing cholangitis in children. J Pediatr Gastroenterol Nutr. 74(4): 463-470. https://doi.org/10.1097/MPG.0000000000003359; PMid:35703948

43. Laidlaw ST, Stamps R, Booker DJ, Brown MJ, Sokol RJ. (1997). Immune hemolytic anemia due to diclofenac. Immunohematology. 13(1): 9-11. https://doi.org/10.21307/immunohematology-2019-692; PMid:15387791

44. Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, Lakatos PL. (2003). Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol. 9(10): 2300-2307. https://doi.org/10.3748/wjg.v9.i10.2300; PMid:14562397 PMCid:PMC4656482

45. Liao L, Xu Y, Wei H, Qiu Y, Chen W, Huang J et al. (2019). Blood cell parameters for screening and diagnosis of hereditary spherocytosis. J Clin Lab Anal. 33(4): e22844. https://doi.org/10.1002/jcla.22844; PMid:30945356 PMCid:PMC6528600

46. Loftus EV Jr. (2004). Management of extraintestinal manifestations and other complications of inflammatory bowel disease. Curr Gastroenterol Rep. 6(6): 506-513. https://doi.org/10.1007/s11894-004-0073-7; PMid:15527681

47. Mărginean CO, Meliţ LE, Mocanu S, Mărginean MO. (2017). Inflammatory bowel diseases: a burden in pediatrics: Case series and a review of the literature. Medicine (Baltimore). 96(11): e6329. https://doi.org/10.1097/MD.0000000000006329; PMid:28296755 PMCid:PMC5369910

48. Morris Pj. (1965). Familial ulcerative colitis. Gut. 6(2): 176-178. https://doi.org/10.1136/gut.6.2.176; PMid:14279722 PMCid:PMC1552268

49. Moshref Razavi H, Yu R. (2021). Rapid acanthocytic schistocytosis and fulminant microangiopathic hemolysis as a preterminal event. Clin Case Rep. 9(5): e04247. https://doi.org/10.1002/ccr3.4247; PMid:34026200 PMCid:PMC8127042

50. Mosli MH, Saadah OI. (2021). Metabolic bone disease in children and adolescent patients with ulcerative colitis. J Pediatr (Rio J). 97(2): 242-247. https://doi.org/10.1016/j.jped.2020.03.003; PMid:32335076 PMCid:PMC9432293

51. Mpakogiannis K, Fousekis FS, Christodoulou DK, Katsanos KH, Narula N. (2023). The current role of Tofacitinib in acute severe ulcerative colitis in adult patients: a systematic review. Dig Liver Dis. 55(10): 1311-1317. https://doi.org/10.1016/j.dld.2023.05.021; PMid:37316363

52. Murawska N, Fabisiak A, Fichna J. (2016). Anemia of chronic disease and iron deficiency anemia in inflammatory bowel diseases: pathophysiology, diagnosis, and treatment. Inflamm Bowel Dis. 22(5): 1198-1208. https://doi.org/10.1097/MIB.0000000000000648; PMid:26818422

53. Naqvi S, Hasan SA, Khalid S, Abbass A, Albors-Mora M. (2018). A unique triad: ulcerative colitis, primary sclerosing cholangitis, and autoimmune hemolytic anemia. Cureus. 10(1): e2068. https://doi.org/10.7759/cureus.2068

54. Nemeş RM, Pop CS, Calagiu D, Dobrin D, Chetroiu D et al. (2016). Аnemia in inflammatory bowel disease more than an extraintestinal complication. Rev Med Chir Soc Med Nat Iasi. 120(1): 34-39.

55. Oztürkmen S, Paç A, Senayl A, Polat TB, Cetin II, Bçakç Z et al. (2010). Schistocytic hemolytic anemia owing to central venous catheter in a child with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 32(6): e233-e235. https://doi.org/10.1097/MPH.0b013e3181e003e2; PMid:20505536

56. Perrotta S, Gallagher PG, Mohandas N. (2008). Hereditary spherocytosis. Lancet. (9647): 1411-1426. https://doi.org/10.1016/S0140-6736(08)61588-3; PMid:18940465

57. Popov J, Caputi V, Nandeesha N, Rodriguez DA, Pai N. (2021). Microbiota-immune interactions in ulcerative colitis and colitis associated cancer and emerging microbiota-based therapies. Int J Mol Sci. 22(21): 11365. https://doi.org/10.3390/ijms222111365; PMid:34768795 PMCid:PMC8584103

58. Powell LW, Seckington RC, Deugnier Y. (2016). Haemochromatosis. Lancet. 388(10045): 706-716. Epub 2016 Mar 12. https://doi.org/10.1016/S0140-6736(15)01315-X; PMid:26975792

59. Ramos MC, Schafernak KT, Peterson LC. (2007). Hereditary pyropoikilocytosis: a rare but potentially severe form of congenital hemolytic anemia. J Pediatr Hematol Oncol. 29(2): 128-129. https://doi.org/10.1097/MPH.0b013e3180320b6f; PMid:17279012

60. Rankine-Mullings AE. (2022). Ulcerative colitis in patients with sickle cell disease: a rare but important co-morbidity. Paediatr Int Child Health. 42(1): 1-4. https://doi.org/10.1080/20469047.2022.2084964; PMid:35694868

61. Reeder SB, Yokoo T, França M, Hernando D, Alberich-Bayarri Á, Alústiza JM et al. (2023). Quantification of liver iron overload with MRI: review and guidelines from the ESGAR and SAR. Radiology. 307(1): e221856. Epub 2023 Feb 21. https://doi.org/10.1148/radiol.221856; PMid:36809220 PMCid:PMC10068892

62. Rodríguez C, Elosua A, Prieto C, Pérez E, Irisarri R, Campillo A et al. (2022). Colectomy rate in ulcerative colitis 15 years after diagnosis: results from the 2001-2003 Navarra cohort. Gastroenterol Hepatol. 45(1): 1-8. English, Spanish. https://doi.org/10.1016/j.gastrohep.2020.11.016; PMid:33545242

63. Rogler G, Singh A, Kavanaugh A, Rubin DT. (2021). Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology. 161(4): 1118-1132. https://doi.org/10.1053/j.gastro.2021.07.042; PMid:34358489 PMCid:PMC8564770

64. Sabharwal KA, Simon MW. (2023). Hereditary spherocytosis: review of cases and discussion of hematologic characteristics and updated diagnostic testing. J Adv Pediatr Child Health. 6: 007-013. https://doi.org/10.29328/journal.japch.1001054

65. Sawczenko A, Sandhu BK, Logan RF, Jenkins H, Taylor CJ et al. (2001). Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet. 357(9262): 1093-1094. https://doi.org/10.1016/S0140-6736(00)04309-9; PMid:11297962

66. Sears DA, Udden MM, Johnston MD. (2003). Red cell osmotic fragility studies in hemoglobin C-beta thalassemia: osmotically resistant microspherocytes. Clin Lab Haematol. 25(6): 367-372. https://doi.org/10.1046/j.0141-9854.2003.00554.x; PMid:14641140

67. Senbanjo I, Akinola A, Kumolu-Johnson T, Igbekoyi O, Oshikoya K. (2020). Inflammatory bowel disease in Nigerian children: case series and management challenges. Paediatr Int Child Health. 40(3): 143-147. https://doi.org/10.1080/20469047.2019.1662658; PMid:31495301

68. Steward SC, Chauvenet AR, O'Suoji C. (2014). Hereditary spherocytosis: Consequences of delayed diagnosis. SAGE Open Med. 2: 2050312114547093. https://doi.org/10.1177/2050312114547093; PMid:26770738 PMCid:PMC4607200

69. Sun HX, Zhu Y. (2023). Progress on regulation of NLRP3 inflammasome by chinese medicine in treatment of ulcerative colitis. Chin J Integr Med. 29(8): 750-760. Epub 2023 Apr 29. https://doi.org/10.1007/s11655-023-3551-1; PMid:37148482

70. Toplicanin A, Toncev L, Matovic Zaric V, Sokic Milutinovic A. (2022). Autoimmune hemolytic anemia in inflammatory bowel disease – report of a case and review of the literature. Life (Basel). 12(11): 1784. https://doi.org/10.3390/life12111784; PMid:36362944 PMCid:PMC9692605

71. Turbiville D, Du X, Yo J, Jana BR, Dong J. (2019). Iron overload in an HFE heterozygous carrier: a case report and literature review. Lab Med. 50(2): 212-217. https://doi.org/10.1093/labmed/lmy065; PMid:30339210

72. Turner D, Hyams J, Markowitz J, Lerer T, Mack DR, Evans J et al. (2009). Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis. 15(8): 1218-1223. https://doi.org/10.1002/ibd.20867; PMid:19161178

73. Uzzan M, Galicier L, Gornet JM, Oksenhendler E, Fieschi C, Allez M et al. (2017). Autoimmune cytopenias associated with inflammatory bowel diseases: Insights from a multicenter retrospective cohort. Dig Liver Dis. 49(4): 397-404. https://doi.org/10.1016/j.dld.2016.12.006; PMid:28063954

74. Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. (2015). Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 21(8): 1982-1992. https://doi.org/10.1097/MIB.0000000000000392; PMid:26154136 PMCid:PMC4511685

75. Viada Bris JF, Velasco Rodríguez-Belvís M, de Lucas Collantes C, Aparicio López C, Martínez de Azagra A, de Lama Caro-Patón G et al. (2019). Ulcerative colitis and atypical hemolytic-uremic syndrome: an unusual but potentially life-threatening complication. Inflamm Bowel Dis. 25(4): e27-e28. https://doi.org/10.1093/ibd/izy226; PMid:29931191

76. Webb TN, Griffiths H, Miyashita Y, Bhatt R, Jaffe R, Moritz M et al. (2015). Atypical hemolytic uremic syndrome and chronic ulcerative colitis treated with eculizumab. Int J Med Pharm Case Reports. 4(5):105-112. https://doi.org/10.9734/IJMPCR/2015/18771; PMid:27135055 PMCid:PMC4849479

77. Wolf G, Thaiss F, Dührsen U, Weh HJ, Hossfeld DK, Stahl RA. (1995). Treatment of thrombotic thrombocytopenic purpura (Moschcowitz's disease) with vincristine. Dtsch Med Wochenschr. 120(13): 442-446. German. https://doi.org/10.1055/s-2008-1055365; PMid:7712934

78. Wong GW, Heneghan MA. (2015). Association of extrahepatic manifestations with autoimmune hepatitis. Dig Dis. 33; Suppl 2: 25-35. https://doi.org/10.1159/000440707; PMid:26641498

79. Yashiro M. (2014). Ulcerative colitis-associated colorectal cancer. World J Gastroenterol. 20(44): 16389-16397. https://doi.org/10.3748/wjg.v20.i44.16389; PMid:25469007 PMCid:PMC4248182

80. Yetgin S, Aslan D, Unal S, Tavil B, Kuşkonmaz B, Elmas SA et al. (2008). Dysplasia and disorder of cell membrane entirety in iron-deficiency anemia. Pediatr Hematol Oncol. 25(6): 492-501. https://doi.org/10.1080/08880010802234804; PMid:18728968